The impact of heart rate variability on asthma disease outcomes

The impact of heart rate variability on asthma disease outcomes - PRAISE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON58037

Enrollment

Registered

2025-04-10

Start date

2026-02-19

Completion date

Unknown

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Children aged 6-18 with a doctor’s diagnosis of asthma, who are regularly using inhaled corticosteroids and did use rescue beta 2-agonists in the previous 3 months will be eligible.

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children aged 6-18 with a doctor’s diagnosis of asthma. Use of rescue beta-2 agonist in last 3 months prior to inclusion. Access to internet connection at home. Using a pressurized metered dosis inhaler Written informed consent of parents/ legal guardians and/or children > 16 yrs/ written informed assent in children > 12 yrs

Exclusion criteria

Exclusion criteria: uncontrolled asthma at study start ((C)-ACT <= 19) Recently (< 4 weeks) started on LABA or combination ICS/LABA

Design outcomes

Primary

Measure	Time frame
Predictive value of heart rate variability for loss of asthma control as assessed with rescue SABA use.	—

Secondary

Measure	Time frame
Predictive value of physical activity, respiratory rate afor loss of asthma control as assessed with rescue SABA use.	—

Countries

Netherlands

Contacts

Public ContactM.W.H. Pijnenburg

Erasmus MC, Universitair Medisch Centrum Rotterdam

m.pijnenburg@erasmusmc.nl0107036263

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026